Study Startup

Veeva Study Startup is designed to manage and expedite the start-up activities of clinical trials by handling various processes such as feasibility, qualification, and the activation of research sites. It helps accelerate the start-up phase to enroll patients more quickly.

During the site selection phase, feasibility surveys are distributed to potential research sites. Responses are used to automatically score and select the appropriate sites for activation. This process ensures only suitable sites progress to the activation phase.

Site activation is facilitated through predefined tasks and milestones managed with adaptable country-specific templates. These templates outline required processes and necessary documentation prior to activating a research site.

The system offers a dashboard view for users to monitor and track the progress and timelines of start-up activities, thereby providing comprehensive visibility into ongoing processes.

• Improve operational efficiency: Experience a 50% reduction in the average time from site selection to readiness for patient enrollment, a 45% faster timeline to enroll the first subject post-site initiation, and a 42% decrease from protocol approval to enrolling the first subject.

The platform enhances operational efficiency by streamlining study start-up, enabling effective collaboration among study partners, and facilitating better decision-making through automated critical path management. This ensures prioritization of dependent and at-risk tasks and milestones.

Veeva Study Startup users such as AstraZeneca, AbbVie, and Fortrea have reported significant improvements, including substantial savings in monitoring time and a centralized tracking system for start-up activities across global trials.